Clinical Trials Browser

Completed × peginterferon alfa-2b × Gastrointestinal × Clear all

NCT00759109 2017-04-07

Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)

Phase 3 Completed

150 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00055809 2013-01-23

Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors

Phase 2 Completed

EndocrineGastrointestinal

Metastatic Gastrointestinal Carcinoid Tumor